There is evidence in the literature supporting that the platelets of CTEPH patients are highly activated; studies have shown that CTEPH patients present increased mean platelet volume, raised percentage of activated GPIIb/IIIa-positive platelets, and elevated GTP-bound levels of RalA [26]. Here, ITGA2B is linked to chronic thromboembolic pulmonary hypertension.